ABSTRACT
Objective Brain atrophy is associated with degenerative neuropathologies as well as clinical status of dementia. Whether dementia influences atrophy independent of neuropathologies is not known. In this study, we examined the pattern of atrophy associated with dementia while accounting for the most common dementia-related neuropathologies.
Methods We used data from National Alzheimer’s Coordinating Center (NACC, N=129) and Alzheimer’s Disease Neuroimaging Initiative (ADNI, N=47) participants with suitable in-vivo 3D-T1w MRI and autopsy data. We determined dementia status at visit closest to MRI. We examined the following dichotomized neuropathological variables: Alzheimer’s disease neuropathology, hippocampal sclerosis, Lewy Bodies, cerebral amyloid angiopathy, atherosclerosis. Voxel-based morphometry (VBM) identified areas associated with dementia after accounting for neuropathologies. Identified regions of interest were further analyzed. We used multiple linear regression models adjusted for neuropathologies and demographic variables.
Results We found strong associations for dementia with volumes of the hippocampus, amygdala, and parahippocampus (semi-partial correlations≥0.28, P<0.0001 for all regions in NACC; semi-partial correlations≥0.35, P≤0.01 for hippocampus and parahippocampus in ADNI). Dementia status accounted for more unique variance in atrophy in these structures (∼8%) compared with neuropathological variables; the only exception was hippocampal sclerosis which accounted for more variance in hippocampal atrophy (10%).
Conclusion Even after accounting for the most common neuropathologies, dementia still had among the strongest correlations with atrophy of medial temporal lobe structures. This suggests that atrophy of the medial temporal lobe is most related to clinical status of dementia as opposed to Alzheimer’s or other neuropathologies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research funding was provided by the following grants: R01AG062706, R01AG021055.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Alzheimer’s Coordinating Center (NACC) database receives contributions from multiple Alzheimer’s Disease Research Centers (ADRCs) across the country, and each is approved by their local Institutional Review Board (IRB), and the various Alzheimer’s Disease Neuroimaging Initiative (ADNI) sites are likewise approved by each institution’s respective IRB: this is stated in the text of the Methods section of the manuscript. Since this a retrospective study using anonymized data, the authors did not obtain consent; however, consent was obtained at each site that contributed data in accordance with their local IRBs.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
Research Support: R01AG062706
R01AG021055
Disclosures: Dr. Davis C. Woodworth reports no disclosures
Dr. Nasim Sheikh-Bahaei reports no disclosures
Kiana A. Scambray reports no disclosures
Dr. Michael J. Phelan reports no disclosures
Dr. Mari Perez-Rosendahl reports no disclosures
Dr. Claudia H. Kawas reports no disclosures
Dr. Maria M. Corrada reports no disclosures
Dr. S. Ahmad Sajjadi reports no disclosures
Data Availability
National Alzheimer’s Coordinating Center (NACC) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) data are freely available to researchers upon request.